http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Chunjing Wang (검색결과 4 건)
- 무료
- 기관 내 무료
- 유료
-
Fujing Wang,Chunjing Wang,Zhen Wang,Yue Zhao 대한위암학회 2023 Journal of gastric cancer Vol.23 No.2
Purpose: This study aimed to evaluate the efficacy and safety of neoadjuvant programmed cell death-1 (PD-1) inhibitors plus apatinib and chemotherapy (PAC) in patients with locally advanced gastric cancer (LAGC). Materials and Methods: Seventy-three patients with resectable LAGC were enrolled and named the PAC group (n=39) or apatinib plus chemotherapy (AC) group (n=34) based on the treatment they chose. Neoadjuvant therapy was administered in a 21-day cycle for 3 consecutive cycles, after which surgery was performed. Results: The PAC group exhibited a higher objective response rate than the AC group (74.4% vs. 58.8%, P=0.159). Moreover, the PAC group showed a numerically better response profile than the AC group (P=0.081). Strikingly, progression-free survival (PFS) (P=0.019) and overall survival (OS) (P=0.049) were prolonged, whereas disease-free survival (DFS) tended to be longer in the PAC group than in the AC group (P=0.056). Briefly, the 3-year PFS, DFS, and OS rates were 76.1%, 76.1%, and 86.7% in the PAC group and 46.9%, 49.9%, and 70.3% in the AC group, respectively. Furthermore, PAC (vs. AC) treatment (hazard ratio=0.286, P=0.034) was independently associated with prolonged PFS in multivariate Cox regression analyses. The incidence of adverse events did not differ between the two groups (all P>0.05), where leukopenia, anemia, hypertension, and other adverse events were commonly observed in the PAC group. Conclusions: Neoadjuvant PAC therapy may achieve a preferable pathological response, delayed progression, and prolonged survival compared to AC therapy with a similar safety profile in patients with LAGC; however, further validation is warranted.
-
Xiaohui Zhang,Xuquan Ji,Junchen Wang,Yubo Fan,Chunjing Tao 대한의용생체공학회 2023 Biomedical Engineering Letters (BMEL) Vol.13 No.2
real-time for laparoscopic image-guided navigation. The stereo vision method for intraoperative tissue 3D reconstructionhas the most potential for clinical development benefiting from its high reconstruction accuracy and laparoscopy compatibility. However, existing stereo vision methods have difficulty in achieving high reconstruction accuracy in real time. Also,intraoperative tissue reconstruction results often contain complex background and instrument information that preventsclinical development for image-guided systems. Taking laparoscopic partial nephrectomy (LPN) as the research object, thispaper realizes a real-time dense reconstruction and extraction of the kidney tissue surface. The central symmetrical Censusbased semi-global block stereo matching algorithm is proposed to generate a dense disparity map. A GPU-based pixel-bypixelconnectivity segmentation mechanism is designed to segment the renal tissue area. An in-vitro porcine heart, in-vivoporcine kidney and offline clinical LPN data were performed to evaluate the accuracy and effectiveness of our approach. The algorithm achieved a reconstruction accuracy of ± 2 mm with a real-time update rate of 21 fps for an HD image size of960 × 540, and 91.0% target tissue segmentation accuracy even with surgical instrument occlusions. Experimental resultshave demonstrated that the proposed method could accurately reconstruct and extract renal surface in real-time in LPN. Themeasurement results can be used directly for image-guided systems. Our method provides a new way to measure geometricinformation of target tissue intraoperatively in laparoscopy surgery.
-
Li Shenglong,Zheng Hao,Ge Qinghong,Xia Shuli,Zhang Ke,Wang Chunjing,Wang Fujing 대한암예방학회 2023 Journal of cancer prevention Vol.28 No.3
This study aimed to investigate the efficacy and safety of apatinib plus programmed cell death protein 1 (PD-1) blockades for patients with metastatic colorectal cancer (CRC) who were refractory to the standard regimens. In this retrospective study, patients with metastatic CRC who received apatinib plus PD-1 blockades in clinical practice were included. The initial dosage of apatinib was 250 mg or 500 mg, and PD-1 blockades were comprised of camrelizumab, sintilimab and pembrolizumab. Efficacy and safety data were collected through the hospital’s electronic medical record system. From October 2018 to March 2022, a total of 43 patients with metastatic CRC were evaluated for efficacy and safety. The results showed an objective response rate of 25.6% (95% CI, 13.5%-41.2%) and a disease control rate of 72.1% (95% CI, 56.3%-84.7%). The median progression-free survival (PFS) of the cohort was 5.8 months (95% CI, 3.81-7.79), and the median overall survival (OS) was 10.3 months (95% CI, 5.75-14.85). The most common adverse reactions were fatigue (76.7%), hypertension (72.1%), diarrhea (62.8%), and hand-foot syndrome (51.2%). Multivariate Cox regression analysis revealed that Eastern Cooperative Oncology Group (ECOG) performance status and location of CRC (left or right-side) were independent factors to predict PFS of patients with metastatic CRC treated with the combination regimen. Consequently, the combination of apatinib and PD-1 blockades demonstrated potential efficacy and acceptable safety for patients with treatment-refractory metastatic CRC. This conclusion should be confirmed in prospective clinical trials subsequently
-
BMB Reports : Poly(ADP-ribose) protects vascular smooth muscle cells from oxidative DNA damage
( Chao Zhang ),( Tao Luo ),( Shijun Cui ),( Yongquan Gu ),( Chunjing Bian ),( Yibin Chen ),( Xiaochun Yu ),( Zhonggao Wang ) 생화학분자생물학회 2015 BMB Reports Vol.48 No.6
Vascular smooth muscle cells (VSMCs) undergo death during atherosclerosis, a widespread cardiovascular disease. Recent studies suggest that oxidative damage occurs in VSMCs and induces atherosclerosis. Here, we analyzed oxidative damage repair in VSMCs and found that VSMCs are hypersensitive to oxidative damage. Further analysis showed that oxidative damage repair in VSMCs is suppressed by a low level of poly (ADP-ribosyl)ation (PARylation), a key post-translational modification in oxidative damage repair. The low level of PARylation is not caused by the lack of PARP-1, the major poly(ADP-ribose) polymerase activated by oxidative damage. Instead, the expression of poly(ADP-ribose) glycohydrolase, PARG, the enzyme hydrolyzing poly(ADP-ribose), is significantly higher in VSMCs than that in the control cells. Using PARG inhibitor to suppress PARG activity facilitates oxidative damage-induced PARylation as well as DNA damage repair. Thus, our study demonstrates a novel molecular mechanism for oxidative damage-induced VSMCs death. This study also identifies the use of PARG inhibitors as a potential treatment for atherosclerosis. [BMB Reports 2015; 48(6): 354-359]
KISS연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
